Pomalidomide Side Effects
Medically reviewed by Drugs.com. Last updated on Jun 22, 2024.
Applies to pomalidomide: oral capsule.
Important warnings
This medicine can cause some serious health issues
Oral route (capsule)
Pomalidomide is contraindicated in pregnancy.
Pomalidomide is a thalidomide analogue, and thalidomide is a known human teratogen that causes severe birth defects or embryo-fetal death.
In females who can become pregnant, obtain 2 negative pregnancy test before treatment initiation.
It is required that females of reproductive potential use 2 forms of contraception or abstain from heterosexual sex during and for 4 weeks after stopping treatment with pomalidomide.
The only way to acquire pomalidomide is through a restricted distribution program called POMALYST REMS.
DVT, pulmonary embolism, myocardial infarction, and stroke have been reported in patients with multiple myeloma treated with pomalidomide.
Thromboprophylaxis is recommended, and the regimen choice should be based on assessment of the underlying risk factors of the patient.
Precautions
It is very important that your doctor check your progress at regular visits to see if it is working properly and to allow for a change in the dose. Blood tests may be needed to check for unwanted effects.
Using this medicine while you are pregnant can harm your unborn baby. Pregnancy tests are required before and during treatment with this medicine. Women who are sexually active must use 2 forms of effective birth control together to avoid pregnancy. You should begin using birth control 4 weeks before starting treatment with this medicine. Continue the birth control during treatment, even if the dose is stopped for a short time, and for at least 4 weeks after your last dose. Talk to your doctor about the most effective forms of birth control for you and your partner. Call your doctor right away if you think you are pregnant.
Men who are sexually active must protect their female partner from getting pregnant. Pomalidomide will appear in the semen so male patients must not donate sperm. If you are sexually active, you must use a latex or synthetic condom every time you have sex with a woman who could get pregnant even if you have had a vasectomy. Use a condom for sex during treatment with this medicine, even if the dose is stopped for a short time, and for at least 4 weeks after your last dose. Call your doctor right away if you think your sexual partner may be pregnant.
Do not donate blood while you are taking this medicine and for at least 4 weeks after your last dose.
Using this medicine may increase your risk for having blood clots (eg, deep vein thrombosis, pulmonary embolism, stroke, or heart attack). Your risk for these serious problems is even greater if you have high blood pressure or high cholesterol, or if you smoke cigarettes. Contact your doctor right away if you experience chest pain, confusion, difficulty speaking, double vision, headaches, an inability to move arms, legs or facial muscle, or an inability to speak.
Do not receive pembrolizumab together with pomalidomide or similar medicines and dexamethasone.
Pomalidomide can temporarily lower the number of white blood cells in your blood, increasing the chance of getting an infection. It can also lower the number of platelets, which are necessary for proper blood clotting. If this occurs, there are certain precautions you can take, especially when your blood count is low, to reduce the risk of infection or bleeding:
- If you can, avoid people with infections. Check with your doctor right away if you think you are getting an infection or if you get a fever or chills, cough or hoarseness, lower back or side pain, or painful or difficult urination.
- Check with your doctor right away if you notice any unusual bleeding or bruising, black, tarry stools, blood in the urine or stools, or pinpoint red spots on your skin.
- Be careful when using a regular toothbrush, dental floss, or toothpick. Your medical doctor, dentist, or nurse may recommend other ways to clean your teeth and gums. Check with your medical doctor before having any dental work done.
- Do not touch your eyes or the inside of your nose unless you have just washed your hands and have not touched anything else in the meantime.
- Be careful not to cut yourself when you are using sharp objects such as a safety razor or fingernail or toenail cutters.
- Avoid contact sports or other situations where bruising or injury could occur.
Check with your doctor right away if you have pain or tenderness in the upper stomach, pale stools, dark urine, loss of appetite, nausea, vomiting, or yellow eyes or skin. These could be symptoms of a serious liver problem.
This medicine may cause serious allergic reactions, including anaphylaxis or angioedema, which may be life-threatening and require immediate medical attention. Check with your doctor right away if you have a rash, itching, a large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs, dizziness, fainting, fast heartbeat, trouble breathing or swallowing, or chest tightness while you are using this medicine.
This medicine may cause serious skin reactions, including Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and drug reaction with eosinophilia and systemic symptoms (DRESS). These reactions can be life-threatening and require immediate medical attention. Call your doctor right away if you have a rash, itching, blistering, peeling, or loosening of the skin, fever or chills, cough, sore throat, trouble breathing or swallowing, swelling of your hands, face, mouth, or throat, swollen, painful, or tender lymph glands in the neck, armpit, or groin, or yellow skin or eyes while using this medicine.
This medicine may cause a serious type of reaction called tumor lysis syndrome. Your doctor may give you a medicine to help prevent this. Call your doctor right away if you have a decrease or change in urine amount, joint pain, stiffness, or swelling, lower back, side, or stomach pain, a rapid weight gain, swelling of the feet or lower legs, or unusual tiredness or weakness.
This medicine may cause nerve damage. Check with your doctor right away if you have tingling, burning, numbness, or pain in your hands or feet. These could be symptoms of a nerve condition called peripheral neuropathy.
Pomalidomide may increase your risk of having new cancers (eg, acute myelogenous leukemia). Talk with your doctor about this risk.
This medicine may make you dizzy or confused. Do not drive or do anything else that could be dangerous until you know how this medicine affects you.
Talk with your doctor before using this medicine if you plan to have children. Some women who use this medicine have become infertile (unable to have children).
Avoid cigarette smoking while using this medicine. The blood level may be lower than normal if you smoke.
Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.
Serious side effects of pomalidomide
Along with its needed effects, pomalidomide may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking pomalidomide:
More common side effects
- black, tarry stools
- bladder pain
- bleeding gums
- bloating or swelling of the face, arms, hands, lower legs, or feet
- blood in the urine or stools
- bloody nose
- body aches or pain
- burning, numbness, tingling, or painful sensations
- chest pain
- chills
- cloudy urine
- confusion
- constipation
- cough
- decreased or increased urination
- difficult, burning, or painful urination
- difficulty with breathing
- discouragement
- dizziness
- dry mouth
- ear congestion
- fast or irregular heartbeat
- feeling sad or empty
- fever
- frequent urge to urinate
- headache
- incoherent speech
- increased thirst
- irritability
- lack of appetite
- loss of appetite
- loss of interest or pleasure
- loss of voice
- lower back or side pain
- metallic taste
- muscle pain or cramps
- muscle weakness
- nasal congestion
- nausea
- numbness or tingling in the hands, feet, or lips
- pain
- pale skin
- pinpoint red spots on the skin
- rapid weight gain
- runny nose
- shakiness in the legs, arms, hands, or feet
- sneezing
- sore throat
- stomach pain
- tightness in the chest
- trembling or shaking of the hands or feet
- trouble concentrating
- trouble sleeping
- troubled breathing with exertion
- ulcers, sores, or white spots in the mouth
- unsteadiness or awkwardness
- unusual bleeding or bruising
- unusual weight gain or loss
- vomiting
- weakness in the arms, hands, legs, or feet
Less common side effects
- anxiety
- dizziness or lightheadedness
- fainting
- pain, redness, or swelling in the arm or leg
- troubled breathing
Incidence not known
- blistering, peeling, or loosening of the skin
- diarrhea
- difficulty in passing urine (dribbling)
- itching
- joint pain
- red skin lesions, often with a purple center
- red, irritated eyes
- unusual tiredness or weakness
- weakness or heaviness of the legs
- yellow eyes or skin
Other side effects of pomalidomide
Some side effects of pomalidomide may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
- back pain
- blurred vision
- decreased appetite
- difficulty with moving
- flushed, dry skin
- fruit-like breath odor
- increased hunger
- increased sweating
- lack or loss of strength
- muscle spasms or stiffness
- night sweats
- rash
Incidence not known
- feeling of constant movement of self or surroundings
- sensation of spinning
For healthcare professionals
Applies to pomalidomide: oral capsule.
Cardiovascular adverse events
- Common (1% to 10%): Deep vein thrombosis, pulmonary embolism, myocardial infarction, stroke, cardiac failure
- Frequency not reported: Atrial fibrillation, angina pectoris, congestive cardiac failure, hypotension[Ref]
Hematologic
- Very common (10% or more): Neutropenia (53%), anemia (46%), thrombocytopenia (27%), leukopenia (20%), lymphopenia (15%)
- Common (1% to 10%): Febrile neutropenia, neutropenic sepsis, decreased neutrophil count, decreased white blood cell count, decreased platelet count, pancytopenia
- Frequency not reported: Decreased lymphocyte count, septic shock, decreased hemoglobin[Ref]
Hepatic
- Common (1% to 10%): Increased ALT
- Uncommon (0.1% to 1%): Hepatitis, hyperbilirubinemia
- Frequency not reported: Increased AST
- Postmarketing reports: Hepatic failure[Ref]
Hypersensitivity
- Postmarketing reports: Allergic reactions (e.g., angioedema, urticaria)[Ref]
Nervous system
- Very common (10% or more): Dizziness (22%), peripheral neuropathy (22%), neuropathy (18%), headache (15%), tremor (13%), confusional state (13%)
- Common (1% to 10%): Depressed level of consciousness, vertigo
- Frequency not reported: Syncope
- Postmarketing reports: Tumor lysis syndrome[Ref]
Oncologic
- Frequency not reported: Second primary malignancies (e.g., acute myelogenous leukemia)
- Postmarketing reports: Tumor lysis syndrome[Ref]
Respiratory
- Very common (10% or more): Dyspnea (45%), upper respiratory tract infection (37%), pneumonia (34%), cough (22%), epistaxis (17%), productive cough (13%), oropharyngeal pain (11%)
- Common (1% to 10%): Interstitial lung disease, bronchopneumonia, bronchitis, nasopharyngitis, epistaxis
- Frequency not reported: Pneumonitis, chronic obstructive pulmonary disease, pneumocystis jiroveci pneumonia, respiratory syncytial viral, pneumonia streptococcal, lobar pneumonia, lung infection, respiratory failure, bronchospasm[Ref]
Dermatologic
- Very common (10% or more): Rash (21%), hyperhidrosis (16%), pruritus (15%), night sweats (13%), dry skin (11%)
- Frequency not reported: Cellulitis[Ref]
Gastrointestinal
- Very common (10% or more): Constipation (37%), nausea (36%), diarrhea (36%), vomiting (14%)
- Very rare (less than 0.01%): Clostridium difficile colitis
- Frequency not reported: Abdominal pain[Ref]
Genitourinary
- Very common (10% or more): Urinary tract infection (17%)
- Common (1% to 10%): Urinary retention, pelvic pain
- Frequency not reported: Urosepsis[Ref]
Metabolic
- Very common (10% or more): Decreased appetite (23%), hypercalcemia (22%), hyperglycemia (15%), decreased weight (15%), hyponatremia (13%), hypokalemia (12%), hypocalcemia (12%), increased weight (11%)
- Common (1% to 10%): Dehydration, hyperkalemia
- Frequency not reported: Failure to thrive[Ref]
Musculoskeletal
- Very common (10% or more): Back pain (35%), musculoskeletal chest pain (23%), muscle spasms (22%), bone pain (18%), arthralgia (17%), muscular weakness (14%), musculoskeletal pain (12%)
- Common (1% to 10%): Extremity pain
- Frequency not reported: Femur fracture, fall, compression fracture, spinal compression fracture[Ref]
Psychiatric
- Very common (10% or more): Insomnia (16%), anxiety (13%)
- Frequency not reported: Mental status change[Ref]
Renal
- Very common (10% or more): Increased blood creatinine (19%), renal failure (15%)[Ref]
Other
- Very common (10% or more): Fatigue and asthenia (63%), pyrexia (32%), peripheral edema (25%), chills (13%)
- Frequency not reported: Pain, general physical health deterioration, non-cardiac chest pain, multi-organ failure, viral infection[Ref]
Immunologic
- Very common (10% or more): Infection (55%)
- Common (1% to 10%): Sepsis[Ref]
See also:
Abecma
Abecma is a CAR T cell therapy used to treat relapsed refractory multiple myeloma (RRMM); it is a ...
Tecvayli
Tecvayli (teclistamab) is a treatment for relapsed or refractory multiple myeloma. Includes ...
Carvykti
Carvykti (ciltacabtagene autoleucel) is a treatment for relapsed or refractory multiple myeloma ...
Talvey
Talvey is used to treat relapsed or refractory multiple myeloma. Includes Talvey side effects ...
Decadron
Decadron is used for addison's disease, adrenal insufficiency, adrenocortical insufficiency ...
Revlimid
Revlimid is used to treat types of multiple myeloma, mantle cell lymphoma, follicular lymphoma and ...
Taxol
Taxol (paclitaxel) is used to treat breast cancer, lung cancer, and ovarian cancer. Includes Taxol ...
Darzalex
Darzalex (daratumumab) is a target therapy used to treat multiple myeloma. Includes DARZALEX uses ...
Velcade
Velcade injection is used to treat multiple myeloma and mantle cell lymphoma. Includes Velcade side ...
Paclitaxel
Paclitaxel systemic is used for breast cancer, breast cancer, adjuvant, breast cancer, metastatic ...
References
1. Cerner Multum, Inc. "UK Summary of Product Characteristics."
2. Cerner Multum, Inc. "Australian Product Information."
3. (2013) "Product Information. Pomalyst (pomalidomide)." QLT Phototherapeutics Inc
More about pomalidomide
- Check interactions
- Compare alternatives
- Reviews (3)
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Pomalidomide side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.